Showing results (51-60 of 324) with videos related to

Sort By:
Pageof 33
American Journal of Physiology. Heart and Circulatory Physiology|February 21, 2006
LRP and alphavbeta3 mediate tPA activation of smooth muscle cellsSa'ed Akkawi, Taher Nassar, Mark Tarshis, et al.
American Journal of Physiology. Heart and Circulatory Physiology|January 27, 2009
Inhibition of integrin alphavbeta3 prevents urokinase plasminogen activator-mediated impairment of cerebrovasodilation after cerebral hypoxia/ischemiaJ Willis Kiessling, Douglas B Cines, Abd Al-Roof Higazi, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 5, 2017
Complement-activation fragment C4a mediates effector functions by binding as untethered agonist to protease-activated receptors 1 and 4HongBin Wang, Daniel Ricklin, John D Lambris
Molecular Immunology|October 6, 2009
Recent developments in low molecular weight complement inhibitorsHongchang Qu, Daniel Ricklin, John D Lambris
Frontiers in Immunology|May 17, 2021
The Promiscuous Profile of Complement Receptor 3 in Ligand Binding, Immune Modulation, and PathophysiologyChristina Lamers, Carla Johanna Plüss, Daniel Ricklin
Blood|March 11, 2011
Flow-dependent channel formation in clots by an erythrocyte-bound fibrinolytic agentKathryn C Gersh, Sergei Zaitsev, Douglas B Cines, et al.
Blood|April 28, 2009
The ITP syndrome: pathogenic and clinical diversityDouglas B Cines, James B Bussel, Howard A Liebman, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 21, 2009
Soluble urokinase receptor conjugated to carrier red blood cells binds latent pro-urokinase and alters its functional profileJuan-Carlos Murciano, Abd Al-Roof Higazi, Douglas B Cines, et al.
Pageof 33